Gross Profit Trends Compared: Zoetis Inc. vs United Therapeutics Corporation

Zoetis vs United Therapeutics: A Decade of Gross Profit Growth

__timestampUnited Therapeutics CorporationZoetis Inc.
Wednesday, January 1, 201411626360003068000000
Thursday, January 1, 201513967250003027000000
Friday, January 1, 201615261000003222000000
Sunday, January 1, 201716196000003532000000
Monday, January 1, 201814291000003914000000
Tuesday, January 1, 201913312000004268000000
Wednesday, January 1, 202013752000004618000000
Friday, January 1, 202115630000005473000000
Saturday, January 1, 202217896000005626000000
Sunday, January 1, 202320700000005834000000
Loading chart...

Igniting the spark of knowledge

Gross Profit Trends: Zoetis Inc. vs United Therapeutics Corporation

In the ever-evolving landscape of the pharmaceutical industry, understanding financial trends is crucial. This analysis compares the gross profit trajectories of Zoetis Inc. and United Therapeutics Corporation from 2014 to 2023. Over this period, Zoetis Inc. consistently outperformed United Therapeutics, with a remarkable 90% increase in gross profit, peaking at approximately $5.8 billion in 2023. In contrast, United Therapeutics saw a 78% rise, reaching around $2.1 billion in the same year. Notably, Zoetis maintained a steady upward trend, while United Therapeutics experienced fluctuations, particularly between 2017 and 2019. These insights highlight Zoetis's robust growth strategy and market positioning, making it a formidable player in the industry. As the pharmaceutical sector continues to expand, these trends offer valuable insights for investors and stakeholders looking to navigate this dynamic market.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025